A recent article produced discussing Clay calcination technology. Specifically focused on reducing the global cement industry carbon burden.
Clay calcination technology: state-of-the-art review by the RILEM TC 282-CCL, published 20 December 2021.
Abstract:
The use of calcined clays as supplementary cementitious materials provides the opportunity to significantly reduce the cement industry’s carbon burden; however, use at a global scale requires a deep understanding of the extraction and processing of the clays to be used, which will uncover routes to optimise their reactivity. This will enable increased usage of calcined clays as cement replacements, further improving the sustainability of concretes produced with them. Existing technologies can be adopted to produce calcined clays at an industrial scale in many regions around the world. This paper, produced by RILEM TC 282-CCL on calcined clays as supplementary cementitious materials (working group 2), focuses on the production of calcined clays, presents an overview of clay mining, and assesses the current state of the art in clay calcination technology, covering the most relevant aspects from the clay deposit to the factory gate. The energetics and associated carbon footprint of the calcination process are also discussed, and an outlook on clay calcination is presented, discussing the technological advancements required to fulfil future global demand for this material in sustainable infrastructure development.
The article was produced by RILEM 282 - A technical committee consisting of 68 member from across academia. - Cant confirm whether there are any links to UoN.
- Forums
- ASX - By Stock
- Carbon Capture
ADN
andromeda metals limited
Add to My Watchlist
8.33%
!
1.3¢

A recent article produced discussing Clay calcination...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.001(8.33%) |
Mkt cap ! $49.59M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.2¢ | $19.63K | 1.529M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 23922763 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 7673577 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 23922763 | 0.012 |
30 | 12691745 | 0.011 |
36 | 20296677 | 0.010 |
9 | 8062464 | 0.009 |
8 | 7649375 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 7543070 | 22 |
0.014 | 7300945 | 13 |
0.015 | 4712698 | 11 |
0.016 | 4227000 | 7 |
0.017 | 554297 | 5 |
Last trade - 16.20pm 02/07/2025 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online